A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway.
Zhang Z, Mao H, Du X, Zhu J, Xu Y, Wang S, Xu X, Ji P, Yu Y, Cao B, Han K, Hou T, Xu Z, Kong Y, Jiang G, Tang X, Qiao C, Mao X.
Zhang Z, et al. Among authors: wang s.
Oncotarget. 2016 Feb 23;7(8):9296-308. doi: 10.18632/oncotarget.6974.
Oncotarget. 2016.
PMID: 26814430
Free PMC article.